Enterprise Investors has acquired a 77% stake in Formeds, a leading Polish premium supplement brand, to enhance its growth strategy in the health and wellness sector.

Target Company Information

Enterprise Investors Fund IX has announced the acquisition of a 77% stake in Formeds, a leading Polish premium brand specializing in vitamins, minerals, and supplements with a commitment to purity. This transaction represents a strategic partnership with Waldemar Pilch, the company's co-owner and president, and aligns with Enterprise Investors' strategy of supporting rapidly growing firms in the health and wellness sector. The financial terms of the deal, which is pending approval from the Office of Competition and Consumer Protection, have not been disclosed.

Founded in 2012, Formeds has established a strong presence in the highly competitive supplement market by adhering to a philosophy of clean formulations, meaning that its products are free from unnecessary fillers, preservatives, and colorings. Formeds' offerings cater to the increasing demands of consumers seeking simple, effective, and high-quality solutions to support their health and well-being. The global market for vitamins, minerals, and dietary supplements is experiencing significant growth, driven by the popularity of healthy lifestyles, preventative health measures, and the desire for longevity. With its high-quality products and commitment to clean formulations, Formeds is well-positioned to capitalize on this trend.

Industry Overview in Poland

The dietary supplement industry in Poland is robust and continues to expand as more consumers seek to enhance their health and wellness through various products. Currently, Polish consumers are increasingly awa

View Source

Similar Deals

Scanderia Venture Navimed

2023

Strategic Partnership Medical Monitoring Systems Poland
Glenmark Celon Pharma S.A.

Strategic Partnership Generic Pharmaceuticals Poland
Fresenius Kabi Polpharma Biologics

Strategic Partnership Bio Therapeutic Drugs Poland
Boston Scientific Nalu Medical

2026

Strategic Partnership Medical Devices & Implants United States of America
Barça Innovation Hub Omniscope

2025

Strategic Partnership Biotechnology & Medical Research (NEC) Spain
Wedbush Financial Services Trigon

2025

Strategic Partnership Investment Banking Poland

Enterprise Investors

invested in

Formeds

in 2025

in a Strategic Partnership deal

Disclosed details

Revenue: $15M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert